Early Phase 1 Hepatocellular Carcinoma Clinical Trials
5 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–5 of 5 trials
Recruiting
Early Phase 1
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
Solid CancerGPC3 Positive Hepatocellular Carcinoma
Beijing GoBroad Hospital30 enrolled2 locationsNCT07242417
Recruiting
Early Phase 1
Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer
NSCLC (Advanced Non-small Cell Lung Cancer)HCC - Hepatocellular Carcinoma
Wondercel Biotech (ShenZhen)60 enrolled2 locationsNCT06653023
Recruiting
Early Phase 1
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients
Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital37 enrolled1 locationNCT06418659
Recruiting
Early Phase 1
Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)
Hepatocellular Carcinoma (HCC)
Koo Foundation Sun Yat-Sen Cancer Center43 enrolled4 locationsNCT04601428
Recruiting
Early Phase 1
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine12 enrolled1 locationNCT06652243